| Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition LR Ferguson, H Chen, AR Collins, M Connell, G Damia, S Dasgupta, ... Seminars in cancer biology 35, S5-S24, 2015 | 358 | 2015 |
| Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy S Prakash, M Malhotra, W Shao, C Tomaro-Duchesneau, S Abbasi Advanced drug delivery reviews 63 (14-15), 1340-1351, 2011 | 308 | 2011 |
| Designing a broad-spectrum integrative approach for cancer prevention and treatment KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, ... Seminars in cancer biology 35, S276-S304, 2015 | 302 | 2015 |
| Life in 3D is never flat: 3D models to optimise drug delivery KA Fitzgerald, M Malhotra, CM Curtin, FJ O'Brien, CM O'Driscoll Journal of Controlled Release 215, 39-54, 2015 | 247 | 2015 |
| Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis S Sebak, M Mirzaei, M Malhotra, A Kulamarva, S Prakash International journal of nanomedicine, 525-532, 2010 | 219 | 2010 |
| Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases M Malhotra, C Tomaro-Duchesneau, S Prakash Biomaterials 34 (4), 1270-1280, 2013 | 215 | 2013 |
| Intranasal delivery of targeted polyfunctional gold–iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and … UK Sukumar, RJC Bose, M Malhotra, HA Babikir, R Afjei, E Robinson, ... Biomaterials 218, 119342, 2019 | 179 | 2019 |
| Human Serum Albumin Nanoparticles for Use in Cancer Drug Delivery: Process Optimization and In Vitro Characterization N Lomis, S Westfall, L Farahdel, M Malhotra, D Shum-Tim, S Prakash Nanomaterials 6 (6), 116, 2016 | 172 | 2016 |
| Nanoparticles and the Blood-Brain Barrier: Advancing from In-Vitro Models Towards Therapeutic Significance DJ Mc Carthy, M Malhotra, AM O’Mahony, JF Cryan, CM O’Driscoll Pharmaceutical research 32, 1161-1185, 2015 | 135 | 2015 |
| A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis M Malhotra, C Lane, C Tomaro-Duchesneau, S Saha, S Prakash International journal of nanomedicine, 485-494, 2011 | 122 | 2011 |
| The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics KA Fitzgerald, J Guo, EG Tierney, CM Curtin, M Malhotra, R Darcy, ... Biomaterials 66, 53-66, 2015 | 118 | 2015 |
| Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA M Malhotra, C Tomaro-Duchesneau, S Saha, I Kahouli, S Prakash International journal of nanomedicine, 2041-2052, 2013 | 114 | 2013 |
| Microencapsulation for the therapeutic delivery of drugs, live mammalian and bacterial cells, and other biopharmaceutics: current status and future directions C Tomaro-Duchesneau, S Saha, M Malhotra, I Kahouli, S Prakash Journal of pharmaceutics 2013, 2013 | 113 | 2013 |
| The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease JC Evans, M Malhotra, JF Cryan, CM O'Driscoll British journal of pharmacology 173 (21), 3041-3079, 2016 | 104 | 2016 |
| Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats C Tomaro-Duchesneau, S Saha, M Malhotra, ML Jones, A Labbé, ... Applied microbiology and biotechnology 98, 115-126, 2014 | 91 | 2014 |
| Detection of molecular residual disease using personalized circulating tumor DNA assay in patients with colorectal cancer undergoing resection of metastases F Loupakis, S Sharma, M Derouazi, S Murgioni, P Biason, MD Rizzato, ... JCO Precision Oncology 5, 1166-1177, 2021 | 84 | 2021 |
| Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach M Westemeyer, J Saucier, J Wallace, SA Prins, A Shetty, M Malhotra, ... Genetics in Medicine 22 (8), 1320-1328, 2020 | 81 | 2020 |
| Orally delivered microencapsulated live probiotic formulation lowers serum lipids in hypercholesterolemic hamsters J Bhathena, C Martoni, A Kulamarva, AM Urbanska, M Malhotra, ... Journal of Medicinal Food 12 (2), 310-319, 2009 | 80 | 2009 |
| A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor KA Fitzgerald, M Malhotra, M Gooding, F Sallas, JC Evans, R Darcy, ... International journal of pharmaceutics 499 (1-2), 131-145, 2016 | 77 | 2016 |
| Design and validation of an orally administrated active L. fermentum-L. acidophilus probiotic formulation using colorectal cancer Apc Min/+ mouse model I Kahouli, M Malhotra, S Westfall, MA Alaoui-Jamali, S Prakash Applied Microbiology and Biotechnology 101, 1999-2019, 2017 | 74 | 2017 |
